Fondation Apicil   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Lyon France (2004)

Organization Overview

First Clinical Trial
2009
NCT01194843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Fondation Apicil

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 3)

Colic (Phase 2)

Emergencies (Phase 4)

Inflammation (Phase 3)

Neuralgia (Phase 3)

Pain, Postoperative (Phase 3)

Renal Colic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 14